In this resource library we share documents, presentations, forms, videos and useful links from Pinnacle and the wider sector.
Use the search box and filters to help find what you're looking for.
Can't find what you need? Try searching in programmes.
Aotearoa New Zealand is changing its diagnostic threshold for diabetes from 1 April 2026 to align with WHO guidance and international definitions. This is expected to move a small number of people currently classified as having prediabetes into the diabetes category. Across the Pinnacle network, this could affect approximately 295 people. We wanted to give practices early notice and share some initial guidance, including FAQs. Te Whatu Ora Health NZ is expected to issue a national announcement ahead of 1 April, along with supporting resources, which we will share as they become available.
In October 2024, Pharmac introduced funded diabetes technology for people living with type 1 diabetes. Most people who choose to use this technology are now established on CGM, and more than 60 per cent are using insulin pumps or automated insulin delivery systems.
As more of these patients begin requesting prescriptions for pump and CGM consumables through primary care, we’ve created this guide to support you with the prescribing process.
Jo Scott-Jones and Dave Maplesden discuss empagliflozin and ketoacidosis, decision to fund fosfomycin in the community, latent autoimmune diabetes and more.
Jo Scott-Jones and Dave Maplesden discuss treatment refusal, salty navels, warts and gels, coffee and pre-diabetes, and more.
Jo Scott-Jones and Dave Maplesden discuss deprescribing, fever in children, pain management and more.
Jo Scott-Jones and Dave Maplesden discuss diverticulitis, new free resources available through Healthpathways, a financial benefits WINZ resource, and more.
A guide for clinical management of type 2 diabetes, including information from a variety of sources. The guide is intended to support nurses at all levels to develop their knowledge and clinical reasoning in diabetes care.
From 30 September 2024, the following insulins will no longer be available in Aotearoa New Zealand: Penmix30, Penmix50 and Mixtard30. NZSSD has issued recommendations for switching to alternative insulins.
A guide for clinical management of type 2 diabetes, including information from a variety of sources. The guide is intended to support nurses at all levels to develop their knowledge and clinical reasoning in diabetes care.
The Aotearoa Diabetes Collective has created a useful guide with templates for letters to support applications for CGM and empagliflozin (for those already prescribed a GLP1ra) for people living with type 2 diabetes.